Page last updated: 2024-09-02

carboxyamido-triazole and Hepatocellular Carcinoma

carboxyamido-triazole has been researched along with Hepatocellular Carcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Capiod, T; Colosetti, P; Enfissi, A; Prigent, S	1

Other Studies

1 other study(ies) available for carboxyamido-triazole and Hepatocellular Carcinoma

Article	Year
The blocking of capacitative calcium entry by 2-aminoethyl diphenylborate (2-APB) and carboxyamidotriazole (CAI) inhibits proliferation in Hep G2 and Huh-7 human hepatoma cells. Cell calcium, 2004, Volume: 36, Issue:6 Topics: Antineoplastic Agents; Boron Compounds; Calcium; Calcium Channel Blockers; Calcium Channels; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Growth Inhibitors; Humans; Liver Neoplasms; Triazoles	2004

Article

Year

The blocking of capacitative calcium entry by 2-aminoethyl diphenylborate (2-APB) and carboxyamidotriazole (CAI) inhibits proliferation in Hep G2 and Huh-7 human hepatoma cells.

Cell calcium, 2004, Volume: 36, Issue:6

Topics: Antineoplastic Agents; Boron Compounds; Calcium; Calcium Channel Blockers; Calcium Channels; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Growth Inhibitors; Humans; Liver Neoplasms; Triazoles

2004